Noble Biomaterials, Inc.

Noble Biomaterials, Inc.

Private
Scranton, PennsylvaniaFrontier & Industrial Techhttps://www.noblebiomaterials.com

Last Round

Debt

Aug 18, 2022

Total Funding Raised

$8.05M

Momentum Score

25 /100

Company Overview

Noble Biomaterials, Inc. is a materials science company that develops, manufactures, and markets antimicrobial and conductive technologies for applications in the performance apparel, healthcare, industrial, and military markets.

Sector

Frontier & Industrial Tech

Verticals

Advanced Materials, Defense Tech, Medical Devices, Sensors, Sustainable Materials

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

antimicrobial textilessilver fibersmart textilese-textilesanti-odor fabricingredient brandingconductive textilestechnical textilesinfection preventionadvanced materialselectromagnetic shieldingEMI shieldingadvanced wound caremilitary textilesplant-based antimicrobialFDA 510(k) clearance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Noble Biomaterials, Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Noble Biomaterials, Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
DebtAug 18, 2022
DebtOct 18, 2021
Series BFeb 10, 2012

Key People

Founding team and executive leadership

Joel Furey

Founder Chief Commercial Officer, Member, Board Of Directors

Founding Team

pierangelo venturi

CEO

Executive Team

pierangelo Venturi

CEO

Executive Team

Jim Walsh

CFO

Executive Team

Noble Biomaterials, Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2026

    Attending the 2026 PGA Show to showcase material technologies.

  • Nov 12, 2025

    Attending the Functional Fabric Fair in Portland, OR, November 12-13, 2025.

Noble Biomaterials, Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Noble Biomaterials, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Noble Biomaterials, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersScranton, Pennsylvania
Employee Range119
Year Founded1997
Last FundingAug 18, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.